Purchase Order SPE2DP25P0373

Award Date 5/3/25
Potential Completion Date 5/19/25
Potential Value $24K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of meningococcal group vaccines and other pharmaceutical products. The contract is a firm fixed-price purchase order with a ceiling value of $22,699.53 and a completion date of May 19, 2025. The contract is set aside for total small business participation. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of meningococcal group vaccines and other pharmaceutical products, with a ceiling value of $25,221.70. The contract is a firm fixed-price purchase order, with a completion date of May 19, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the...
This federal contract award to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois, is a delivery order under the SPE2DX15D9383 and SPE2DP24F3424 contracts. The contract has a total ceiling value of $1,948.95 and is for the delivery of meningococcal group vaccines. The contract is a firm fixed-price contract and has no set-aside designation. DMS Pharmaceutical Group holds a separate indefinite delivery contract, SPE2DB, with the Defense Logistics...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $75,318 under the Defense Logistics Agency Troop Support Medical's indefinite delivery contract to supply pharmaceutical items. The delivery order is for 8504579401 Meningococcal Polysaccharide Vaccine with performance to be completed by August 2, 2017. No set-aside designation was used for this award. DMS Pharmaceutical Group will fulfill the order from its facility located in Park Ridge, Illinois. As a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a total ceiling value of $1,169.37 and provides for the delivery of a variety of pharmaceutical products, including meningococcal group vaccines, to defense medical facilities worldwide. The contract is a firm fixed-price delivery order awarded under DMS Pharmaceutical Group's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,127.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of September 18, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,253.96 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of YF-VAX 1 DOSE VIALS and has a period of performance through June 6, 2024. DMS Pharmaceutical Group is an experienced government contractor that provides a wide range of branded and generic pharmaceutical products, biologics, and medical supplies to support the recurring...
This federal contract award, with ID SPE2DP25P0242, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,259.38 firm fixed-price purchase order is for the delivery of various pharmaceutical products, including measles, mumps, and rubella vaccines, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) is a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,203.30 contract is for the delivery of M-M-R II vaccine vials, with a completion date of August 7, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which...

This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Meningococcal Group vaccines, with a ceiling value of $23,780.46 and an ultimate completion date of May 19, 2025. The contract is set aside for small businesses. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to federal agencies. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide.

Generated 8/2/25, 9:45 AM